| Literature DB >> 32244777 |
Abstract
Background and objectives: Electromyostimulation (EMS) has been shown to improve body composition, but what biomarkers it affects has not been investigated. The purpose of this study was to compare the EMS-effect of exercises with music on fatness and biomarker levels in obese elderly. Materials andEntities:
Keywords: cytokine; electromyostimulation; exercises with music; percent fat; tumor necrosis factor
Mesh:
Substances:
Year: 2020 PMID: 32244777 PMCID: PMC7231244 DOI: 10.3390/medicina56040158
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Patients’ allocation (consolidated standards for reporting of trials flow diagram). CON: Control group; EMS: Electromyostimulation; EMSG: EMS group
Physical characteristics of the subjects.
| Variables (Unit) | Groups | Mann–Whitney U Test | ||
|---|---|---|---|---|
| CON ( | EMSG ( | Z |
| |
| Age (y) | 71.75 ± 2.73 | 70.38 ± 2.93 | −0.908 | 0.376 |
| Height (cm) | 151.49 ± 2.50 | 151.51 ± 4.02 | −0.328 | 0.769 |
| Weight (kg) | 63.75 ± 3.82 | 63.05 ± 8.78 | −0.272 | 0.810 |
| Percent fat (%) | 38.33 ± 4.31 | 39.21 ± 1.76 | −0.082 | 0.936 |
| VO2max (mL/kg/min) | 23.13 ± 4.25 | 25.34 ± 6.51 | −0.412 | 0.675 |
All data represents the mean ± standard deviation. VO2max: maximum oxygen capacity.
Degrees of category scores by international physical activity questionnaire.
| # | Activity | Criteria |
|---|---|---|
| 1 | Low | • No activity is reported or |
| 2 | Moderate | Either of the following three criteria as below: |
| 3 | High | Any one of the following two criteria as below: |
Equations for calculating physical activity degree as follows; Walking metabolic equivalent (MET)-min/week = 3.3 × min of activity/a day × days per week. Moderate-intensity physical activity MET-min/week = 4.0 × min of activity/a day × days per week. Vigorous-intensity physical activity MET-min/week = 8.0 × min of activity/a day × days per week. Total MET-min/week = Walking MET-min/week + Moderate-intensity physical activity MET-min/week + Vigorous-intensity physical activity MET-min/week.
Differences of controlled variables.
| Items | Week | Groups | ANOVA ( | |||
|---|---|---|---|---|---|---|
| CON ( | EMSG ( | G | T | G × T | ||
| Calorie intake | 4 | 1663.21 ± 124.38 | 1671.36 ± 182.25 | 0.819 | 0.867 | 0.784 |
| (kcal) | 8 | 1688.69 ± 119.85 | 1641.43 ± 193.62 | |||
| Calorie output | 4 | 246.25 ± 51.23 | 258.08 ± 49.25 | 0.910 | 0.442 | 0.919 |
| (kcal) | 8 | 229.97 ± 52.36 | 237.88 ± 51.69 | |||
| PAC | 4 | 1.85 ± 1.45 | 1.83 ± 1.47 | 0.862 | 0.422 | 0.788 |
| scores | 8 | 1.84 ± 1.63 | 1.87 ± 1.78 | |||
All values are expressed as mean ± standard deviation. All groups are scored by low-, moderate-, and high-activity levels. PAC: Physical activity category.
Differences and changes in body composition.
| Items | Groups | ANOVA ( | ||||
|---|---|---|---|---|---|---|
| CON ( | EMSG ( | G | T | G × T | ||
| Body weight | Pre | 63.75 ± 3.82 | 63.05 ± 8.78 | 0.517 | 0.010 | 0.297 |
| (kg) | Post | 62.33 ± 4.17 | 57.54 ± 6.58 | |||
| Skeletal muscle | Pre | 20.46 ± 0.97 | 20.94 ± 2.03 | 0.020 | 0.285 | 0.010 |
| (kg) | Post | 19.82 ± 1.71 | 22.41 ± 2.19 | |||
| Fat mass | Pre | 25.23 ± 2.93 | 26.50 ± 5.50 | 0.649 | 0.014 | 0.007 |
| (kg) | Post | 25.42 ± 2.66 | 22.31 ± 3.89 | |||
| Percent fat | Pre | 38.33 ± 4.31 | 39.21 ± 1.76 | 0.273 | 0.466 | 0.036 |
| (%) | Post | 39.66 ± 2.32 | 34.95 ± 3.82 | |||
| Basal Metabolic | Pre | 1187.00 ± 35.92 | 1188.69 ± 67.98 | 0.004 | 0.249 | 0.001 |
| Rate (kcal) | Post | 1110.17 ± 40.62 | 1237.77 ± 74.40 | |||
All data represents the mean ± standard deviation.
Differences and changes in biomarkers.
| Items (Units) | Groups | ANOVA ( | ||||
|---|---|---|---|---|---|---|
| CON ( | EMSG ( | G | T | G × T | ||
| IL-6 | Pre | 14.29 ± 7.52 | 14.51 ± 7.14 | 0.236 | 0.223 | 0.051 |
| (pg/mL) | Post | 15.41 ± 3.79 | 9.95 ± 6.31 | |||
| TNF-a | Pre | 28.21 ± 8.51 | 27.28 ± 12.35 | 0.039 | 0.555 | 0.001 |
| (pg/mL) | Post | 36.68 ± 11.68 | 20.77 ± 8.64 | |||
| CRP | Pre | 34.33 ± 15.80 | 33.19 ± 10.30 | 0.001 | 0.013 | 0.001 |
| (pg/mL) | Post | 54.65 ± 11.66 | 26.65 ± 8.13 | |||
| RSTN | Pre | 5.92 ± 1.98 | 5.56 ± 2.55 | 0.001 | 0.859 | 0.005 |
| (ng/mL) | Post | 8.43 ± 4.06 | 3.33 ± 1.09 | |||
| CEA | Pre | 2.12 ± 1.21 | 2.24 ± 0.66 | 0.034 | 0.864 | 0.001 |
| (ng/mL) | Post | 2.88 ± 1.07 | 1.42 ± 0.19 | |||
| CK | Pre | 222.92 ± 67.13 | 218.38 ± 51.82 | 0.869 | 0.530 | 0.761 |
| (IU/L) | Post | 230.33 ± 80.64 | 239.69 ± 65.85 | |||
| HDL-C | Pre | 50.92 ± 9.82 | 47.08 ± 9.99 | 0.819 | 0.992 | 0.008 |
| (mg/dL) | Post | 46.33 ± 8.63 | 51.69 ± 7.70 | |||
| LDL-C | Pre | 134.17 ± 43.47 | 145.31 ± 35.44 | 0.332 | 0.005 | 0.009 |
| (mg/dL) | Post | 131.83 ± 36.60 | 97.54 ± 23.88 | |||
All data represents the mean ± standard deviation. IL-6, TNF, CRP, RSTN, CEA, CK, HDL-C, and LDL-C mean interleukin-6, tumor necrosis factor, C-reactive protein, resistin, carcinoembryonic antigen, creatine kinase, high-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol, respectively.